NDAINTRAVENOUSPOWDERPriority Review
Approved
Jun 2005
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20
Mechanism of Action
Pharmacologic Class:
Tetracycline-class Antibacterial
Clinical Trials (5)
Tygacil Drug Use Investigation
Started Apr 2013
116 enrolled
Intra-Abdominal InfectionsSkin Disease, Infectious
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
Started Nov 2012
470 enrolled
Intra-abdominal Infection
Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
Started Mar 2012
12 enrolled
Obesity
Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects
Started Aug 2011
0Skin DiseasesInfection
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
Started Jul 2011
10 enrolled
DiarrheaClostridium Difficile
Loss of Exclusivity
LOE Date
Oct 8, 2030
55 months away
Patent Expiry
Oct 8, 2030